A Study of of Trastuzumab-Mcc-DM1 Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer

This study has been completed.

Study NCT00679211 Information provided by Genentech

First Received: May 14, 2008 Last Updated: December 22, 2011 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	September 2011
Primary Completion Date:	April 2011 (Final data collection date for primary outcome measure)